<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220328054364N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-21</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effectiveness of Chlorhexidine and sodium bicarbonate mouthwash solutions on the onset of Covid-19 symptoms</public_title>
      <acronym></acronym>
      <scientific_title>Comparative study of the effect of two solutions of Chlorhexidine and sodium bicarbonate mouthwash on the onset of Covid-19 related symptoms in vaccinated operating room staff</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64210</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this research, the researcher first enters the study of the operating room personnel by calling in the research environment and explaining the title, taking into account the inclusion criteria, by easy sampling method. In order to balance the number of samples assigned to each of the study groups, the block randomization method will be used and the size of each block will be considered 3. For random allocation with random blocks, a valid website (https://www.sealedenvelope.com/simple-randomiser/v1/lists) will be used, then the samples will be placed in each of the intervention or control groups, Blinding description: In order to blind the study and not inform the staff about the type of mouthwash, the type of solution is not written on the bottles and the type of solution will be determined using coding. Also the bottles are made similar and opaque, and the food coloring is used to match the color of the solutions.In addition, the person analyzing the data will not know the details of the groupings.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Covid-19.</hc_freetext>
      <i_freetext>Intervention 1: In intervention group 1, after preparing dark colored medicine glass bottles that are uniform, the researcher prepares 0.2% Chlorhexidine solution under the brand name Vi-one in the form of mouthwash solutions prepared from the pharmacy and only the bottle is changed. The mouthwash solution is used once in the morning and once in the evening in the amount of 15 ml for one minute. Before using mouthwash, you must use a toothbrush and eat and drink is forbidden for at least half an hour after using mouthwash. Due to the fact that some toothpastes may have antimicrobial properties, in this study, the researcher prepared plain mint toothpaste from Goltash Company and provided samples to all three groups. This toothpaste is simple and without properties. It is antimicrobial. The duration of mouthwash is two weeks, then mouthwash is stopped and personnel are followed for four weeks from the first day of mouthwash to check the onset of symptoms of Quid-19. Personnel are checked. During the four weeks that the staff is monitored, they must record and report their symptoms once a week in the symptom checklist, and if they observe any suspicious signs other than one week apart, they must Make a note of the checklist mentioned. At one-week intervals, a total of four staff members record their symptoms in a symptom checklist four times over a four-week period. The research units are asked to inform the researcher when any of the signs that have already been explained to them appear. The researcher records each of the signs that appear along with the personnel details. PCR testing will be performed on staff if required. By creating a group in WhatsApp software and daily consumption table of mouthwash, the use of mouthwash is reminded and recorded. How to use mouthwash and its important points are written on the bottles and in addition it is explained orally. Intervention 2: In intervention group 2, the researcher prepares dark colored medicine glass bottles that are uniform. Sodium bicarbonate solution is prepared by the researcher as a mouthwash solution of 5.7% (per 100 ml of water containing 5.7 grams of sodium bicarbonate) using an accurate scale with Imperial brand and graduated glasses and after dissolving it , Is poured into glass bottles. The mouthwash solution is used once in the morning and once in the evening in the amount of 15 ml for one minute. Before using mouthwash, you must use a toothbrush and eat and drink is forbidden for at least half an hour after using mouthwash. Due to the fact that some toothpastes may have antimicrobial properties, in this study, the researcher prepared plain mint toothpaste from Goltash Company and provided samples to all three groups. This toothpaste is simple and without properties. It is antimicrobial. The duration of mouthwash is two weeks, then mouthwash is stopped and personnel are followed for four weeks from the first day of mouthwash to check the onset of symptoms of Quid-19. Personnel are checked. During the four weeks that the staff is monitored, they must record and report their symptoms once a week in the symptom checklist, and if they observe any suspicious signs other than one week apart, they must Make a note of the checklist mentioned. At one-week intervals, a total of four staff members record their symptoms in a symptom checklist four times over a four-week period. The research units are asked to inform the researcher when any of the signs that have already been explained to them appear. The researcher records each of the signs that appear along with the personnel details. PCR testing will be performed on staff if required. By creating a group in WhatsApp software and daily consumption table of mouthwash, the use of mouthwash is reminded and recorded. How to use mouthwash and its important points are written on the bottles and in addition it is explained orally. Intervention 3: Control group: Control group: The third mouthwash of the study is a placebo. In this study, purified water is considered. Due to the use of piped drinking water in the preparation of sodium bicarbonate solution, for the placebo, purified drinking water is also piped. Used. According to the rules of placebo, in order for these three solutions to be the same shape and not to cause a problem in blinding, and according to the fact that the Chlorhexidine solution prepared is blue, the researcher added a food coloring of blue liquid which is soluble in water. It uses a small amount of the other two mouthwashes, purified water and sodium bicarbonate. The permissible oral color of the liquid is added with a dropper and in a certain volume of the mouthwash solution and compared with the Chlorhexidine solution to make them look similar in color. The mouthwash solution is used once in the morning and once in the evening in the amount of 15 ml for one minute. Before using mouthwash, you must use a toothbrush and eat and drink is forbidden for at least half an hour after using mouthwash. Due to the fact that some toothpastes may have antimicrobial properties, in this study, the researcher prepared plain mint toothpaste from Goltash Company and provided samples to all three groups. This toothpaste is simple and without properties. It is antimicrobial. The duration of mouthwash is two weeks, then mouthwash is stopped and personnel are followed for four weeks from the first day of mouthwash to check the onset of symptoms of Quid-19. Personnel are checked. During the four weeks that the staff is monitored, they must record and report their symptoms once a week in the symptom checklist, and if they observe any suspicious signs other than one week apart, they must Make a note of the checklist mentioned. At one-week intervals, a total of four staff members record their symptoms in a symptom checklist four times over a four-week period. The research units are asked to inform the researcher when any of the signs that have already been explained to them appear. The researcher records each of the signs that appear along with the personnel details. PCR testing will be performed on staff if required. By creating a group in WhatsApp software and daily consumption table of mouthwash, the use of mouthwash is reminded and recorded. How to use mouthwash and its important points are written on the bottles and in addition it is explained orally.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Once the individuals are unidentifiable, all data will be published, including information about the main outcome as well as contextual variables such as the age and sex of the study participants.

When:
Access period starts 6 months after the results are published

To whom:
Researchers working at academic institutions will have access to the data.

Conditions:
Use of data for 1. Therapeutic 2. Research purposes

Where to obtain:
Hanieh Karami Chamgordani
haniehkarami@nm.mui.ac.ir

How to obtain:
Send a request by contact and provide evidence for use in research or treatment and receive data

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hanieh Karami Chamgordani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery ,Isfahan University of Medical Sciences, Hezar Jerib street, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 7516</telephone>
        <email>haniehkarami@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Akram Aarabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Hezar Jerib street, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 7516</telephone>
        <email>aarabi@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Personnel with an age range of 18-60 years
Get at least two doses of the vaccine
At least two weeks have passed since the second dose of the vaccine was given</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnant personnel
Breastfeeding period
History of allergy to mouthwash solutions
Taking immunosuppressive  drugs
Having Covid-19 in the last two months
Having symptoms of systemic infection</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>B97.21</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>SARS-associated coronavirus as the cause of diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Early detection</i_code>
      <i_code>Early detection</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In intervention group 1, after preparing dark colored medicine glass bottles that are uniform, the researcher prepares 0.2% Chlorhexidine solution under the brand name Vi-one in the form of mouthwash solutions prepared from the pharmacy and only the bottle is changed. The mouthwash solution is used once in the morning and once in the evening in the amount of 15 ml for one minute. Before using mouthwash, you must use a toothbrush and eat and drink is forbidden for at least half an hour after using mouthwash. Due to the fact that some toothpastes may have antimicrobial properties, in this study, the researcher prepared plain mint toothpaste from Goltash Company and provided samples to all three groups. This toothpaste is simple and without properties. It is antimicrobial. The duration of mouthwash is two weeks, then mouthwash is stopped and personnel are followed for four weeks from the first day of mouthwash to check the onset of symptoms of Quid-19. Personnel are checked. During the four weeks that the staff is monitored, they must record and report their symptoms once a week in the symptom checklist, and if they observe any suspicious signs other than one week apart, they must Make a note of the checklist mentioned. At one-week intervals, a total of four staff members record their symptoms in a symptom checklist four times over a four-week period. The research units are asked to inform the researcher when any of the signs that have already been explained to them appear. The researcher records each of the signs that appear along with the personnel details. PCR testing will be performed on staff if required. By creating a group in WhatsApp software and daily consumption table of mouthwash, the use of mouthwash is reminded and recorded. How to use mouthwash and its important points are written on the bottles and in addition it is explained orally.</i_keyword>
      <i_keyword>In intervention group 2, the researcher prepares dark colored medicine glass bottles that are uniform. Sodium bicarbonate solution is prepared by the researcher as a mouthwash solution of 5.7% (per 100 ml of water containing 5.7 grams of sodium bicarbonate) using an accurate scale with Imperial brand and graduated glasses and after dissolving it , Is poured into glass bottles. The mouthwash solution is used once in the morning and once in the evening in the amount of 15 ml for one minute. Before using mouthwash, you must use a toothbrush and eat and drink is forbidden for at least half an hour after using mouthwash. Due to the fact that some toothpastes may have antimicrobial properties, in this study, the researcher prepared plain mint toothpaste from Goltash Company and provided samples to all three groups. This toothpaste is simple and without properties. It is antimicrobial. The duration of mouthwash is two weeks, then mouthwash is stopped and personnel are followed for four weeks from the first day of mouthwash to check the onset of symptoms of Quid-19. Personnel are checked. During the four weeks that the staff is monitored, they must record and report their symptoms once a week in the symptom checklist, and if they observe any suspicious signs other than one week apart, they must Make a note of the checklist mentioned. At one-week intervals, a total of four staff members record their symptoms in a symptom checklist four times over a four-week period. The research units are asked to inform the researcher when any of the signs that have already been explained to them appear. The researcher records each of the signs that appear along with the personnel details. PCR testing will be performed on staff if required. By creating a group in WhatsApp software and daily consumption table of mouthwash, the use of mouthwash is reminded and recorded. How to use mouthwash and its important points are written on the bottles and in addition it is explained orally.</i_keyword>
      <i_keyword>Control group: Control group: The third mouthwash of the study is a placebo. In this study, purified water is considered. Due to the use of piped drinking water in the preparation of sodium bicarbonate solution, for the placebo, purified drinking water is also piped. Used. According to the rules of placebo, in order for these three solutions to be the same shape and not to cause a problem in blinding, and according to the fact that the Chlorhexidine solution prepared is blue, the researcher added a food coloring of blue liquid which is soluble in water. It uses a small amount of the other two mouthwashes, purified water and sodium bicarbonate. The permissible oral color of the liquid is added with a dropper and in a certain volume of the mouthwash solution and compared with the Chlorhexidine solution to make them look similar in color. The mouthwash solution is used once in the morning and once in the evening in the amount of 15 ml for one minute. Before using mouthwash, you must use a toothbrush and eat and drink is forbidden for at least half an hour after using mouthwash. Due to the fact that some toothpastes may have antimicrobial properties, in this study, the researcher prepared plain mint toothpaste from Goltash Company and provided samples to all three groups. This toothpaste is simple and without properties. It is antimicrobial. The duration of mouthwash is two weeks, then mouthwash is stopped and personnel are followed for four weeks from the first day of mouthwash to check the onset of symptoms of Quid-19. Personnel are checked. During the four weeks that the staff is monitored, they must record and report their symptoms once a week in the symptom checklist, and if they observe any suspicious signs other than one week apart, they must Make a note of the checklist mentioned. At one-week intervals, a total of four staff members record their symptoms in a symptom checklist four times over a four-week period. The research units are asked to inform the researcher when any of the signs that have already been explained to them appear. The researcher records each of the signs that appear along with the personnel details. PCR testing will be performed on staff if required. By creating a group in WhatsApp software and daily consumption table of mouthwash, the use of mouthwash is reminded and recorded. How to use mouthwash and its important points are written on the bottles and in addition it is explained orally.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Headache. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Temperatures. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Medical thermometer (Record in the checklist of symptoms).</prim_outcome>
      <prim_outcome>Cough. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Shortness of breath. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Muscular pain. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Sore throat. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Runny nose and nasal congestion. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Sneezing. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Lethargy. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Dizziness. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Anorexia. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Diarrhea. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Vomit. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Decreased sense of taste. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Decreased sense of smell. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Skin rash. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Red and irritated eyes. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Lacrimation. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
      <prim_outcome>Weakness. Timepoint: For 4 weeks, from the beginning of using mouthwash. Method of measurement: Record in the checklist of symptoms.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-11</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Isfahan University of Medical Sciences, Hezar Jarib Ave, Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
